Home allergy
 

Keywords :   


Tag: allergy

From 'Potent' Pollen to Double Whammy Allergy Seasons

2013-05-17 12:17:00| Climate Ark Climate Change & Global Warming Newsfeed

ABC: Climate changes and rising carbon dioxide levels don't just affect the environment. Experts say they also affect your nose. Warmer temperatures and higher carbon dioxide levels mean certain plants will thrive, and those are the plants that tend to make us sneeze during allergy season. Allergies may seem like a minor nuisance, but according to the CDC there are an estimated 50 million Americans living with allergies, and $18 billion is spent every year dealing with the affliction. From hay fever...

Tags: double seasons allergy potent

 

FDA reviewing Merck ragweed allergy therapy

2013-05-08 19:42:40| Biotech - Topix.net

Drugmaker Merck & Co. says the Food and Drug Administration is reviewing its second application to sell a new type of allergy treatment meant to gradually reduce allergic reactions over time, rather than just relieving sneezing, itching and other symptoms temporarily.

Tags: therapy reviewing allergy fda

 
 

Merck Announces FDA Acceptance of Biologics License Application for Investigational Ragweed Pollen Sublingual Allergy Immunotherapy Tablet

2013-05-08 14:30:00| Merck.com - Research & Development News

Dateline City:  WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Biologics License Application (BLA) for its investigational ragweed pollen (Ambrosia artemisiifolia) sublingual allergy immunotherapy tablet has been accepted for review by the U.S. Food and Drug Administration (FDA). On March 27, Merck announced that the FDA had also accepted the BLA for its investigational Timothy grass pollen (Phleum pratense) sublingual allergy immunotherapy tablet. Language:  English Contact HTML:  MerckMedia:Pam Eisele, 908-423-5042Robert Consalvo, 908-423-6595orInvestor:Justin Holko, 908-423-5088 Ticker Slug:  Ticker: MRK Exchange: NYSE read more

Tags: application license acceptance announces

 

2013 Allergy Season Could Be The Worst Ever, Thanks To Climate Change, Some Experts Say

2013-04-01 00:08:00| Climate Ark Climate Change & Global Warming Newsfeed

Climate Nexus: This spring could be the most miserable one ever for those of us with allergies, and we can blame it on climate change. People in the Northeast, in particular, will be among the hardest hit in the aftermath of Hurricane Sandy and this winter's record-setting blizzard, both of which dumped massive amounts of precipitation over the region. "[This] promises a robust allergy season,'' said Leonard Bielory, an allergy and immunology specialist with the Rutgers Center for Environmental Prediction...

Tags: some change say season

 

Merck: FDA Reviewing Tablet to Eliminate Allergy

2013-03-28 17:38:48| Biotech - Topix.net

Drugmaker Merck & Co. said Wednesday that federal regulators are reviewing its application to sell a new type of treatment for grass pollen allergy that gradually reduces allergy symptoms over time, rather than just temporarily relieving the sneezing and itching.

Tags: eliminate reviewing tablet allergy

 

Sites : [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] next »